A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

NCT06215911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Heart Failure With Reduced Ejection Fraction
Cardiovascular Diseases
Heart Diseases

Interventions

DRUG: Tovinontrine (CRD-750)
DRUG: Placebo

Sponsor

Cardurion Pharmaceuticals, Inc.